Search directory

Back to dataset

FLS-DB 2023 clinical data definitions

The Fracture Liaison Service Database (FLS-DB) January to December 2023

You're previewing the first 1 rows of this file.

Data field position	Column A	Column B	Column C	Column D	Column E	Column F	Column G	Column H	Column I	Column J	Column K	Column L	Column M	Column N	Column O	Column P	Column Q	Column R	Column S	Column T	Column U	Column V	Column W	Column X	Column Y	Column Z	Column AA	Column AB	Column AC	Column AD	Column AE	Column AF	Column AG	Column AH	Column AI	Column AJ	Column AK	Column AL	Column AM	Column AN	Column AO	Column AP	Column AQ	Column AR	Column AS	Column AT	Column AU	Column AV	Column AW	Column AX	Column AY	Column AZ	Column BA	Column BB	Column BC	Column BD	Column BE	Column BF	Column BG	Column BH	Column BI	Column BJ	Column BK	Column BL	Column BM	Column BN	Column BO	Column BP	Column BQ	Column BR	Column BS	Column BT	Column BU	Column BV	Column BW	Column BX	Column BY	Column BZ	Column CA	Column CB	Column CC	Column CD	Column CE	Column CF	Column CG	Column CH	Column CI	Column CJ	Column CK	Column CL	Column CM	Column CN	Column CO	Column CP	Column CQ	Column CR	Column CS	Column CT	Column CU	Column CV	Column CW	Column CX	Column CY
Data field	flscode	flsname	Data completeness (%)	Total submitted	Total submitted (spine)	Total submitted (hip)	Total submitted (non-hip, non-spine)	Percentage submitted (spine)	Percentage submitted (hip)	Percentage submitted (non-hip, non-spine)	Total submitted (under 75)	Total submitted (over 75)	Estimated caseload	Percentage of estimated caseload submitted (all patients)	Percentage of estimated caseload submitted (under 75)	Percentage of estimated caseload submitted (over 75)	Number assessed within 90 days (all patients)	Percentage assessed within 90 days	Number DXA within 90 days (all patients)	Percentage DXA within 90 days (all patients)	Number receiving a falls assessment (all patients)	Number receiving a falls assessment (under 75)	Number receiving a falls assessment (over 75)	Percentage receiving a falls assessment (all patients)	Percentage receiving a falls assessment (under 75)	Percentage receiving a falls assessment (over 75)	Number of patients with a treatment recommendation (all patients)	Number of patients with a treatment recommendation (under 75)	Number of patients with a treatment recommendation (over 75)	Percentage of patients with a treatment recommendation (all patients)	Percentage of patients with a treatment recommendation (under 75)	Percentage of patients with a treatment recommendation (over 75)	Oral bisphosphonates - %	Total number of patients receiving bisphosphonates	Zoledronate - %	Total number of patients receiving zoledronate	Denosumab - %	Total number of patients receiving denosumab	Raloxifene - %	Total number of patients receiving raloxifene	Teriparatide - %	Total number of patients receiving teriparatide	Romosozumab - %	Total number of patients receiving romosozumab	Referred to GP - %	Total number of patients referred to a GP	Clinical opinion %	Total number of patient referred for clinical opinion	Number of patients due follow up (non-hip fracture)	Number of patients due follow up (non-hip fracture patients) (under 75)	Number of patients due follow up (non-hip fracture patients) (over 75)	Percentage of patients due follow up (non-hip fracture)	Number of patients due follow up (all patients)	Number of patients started strength and balance (non-hip fracture)	Number of patients started strength and balance (non-hip fracture) (under 75)	Number of patients started strength and balance (non-hip fracture) (over 75)	Percentage of patients started strength and balance (non-hip fracture)	Percentage of patients started strength and balance (non-hip fracture) (under 75)	Percentage of patients started strength and balance (non-hip fracture) (over 75)	Number of patients due follow up (Hip fracture patients)	Number of patients followed up (all fractures)	Number of patients followed up (hip fractures)	Number of patients followed up (non-hip fractures)	Percentage of patients followed up (all fractures)	Percentage of patients followed up (hip fractures)	Percentage of patients followed up (non-hip fractures)	Number of patients commenced bone therapy by 1st follow up	Percentage of patients commenced bone therapy by 1st follow up	Total number of patients receiving oral bisphosphonates	oral bisphosphonates %	Total number of patients receiving zoledronate	zoledronate %	Total number of patients receiving denosumab	denosumab %	Total number of patients receiving raloxifene	raloxifene %	Total number of patients receiving teriparatide	Teriparatide %	Total number of patients receiving romosozumab	Romosozumab %	Total number of patients referred to GP	Referred to GP %	Total number of patients referred for clinical opinion	Referred for clinical opinion %	Number of patients due follow up at 1 year	Number adherent to bone therapy at 12 months	Percentage adherent to bone therapy at 12 months	Total number of patients adherent to oral bisphosphonates	Oral bisphosphonates %	Total number of patients adherent to Zoledronate	Zoledronate %	Total number of patients receiving denosumab	Denosumab - %	Total number of patients receiving raloxifene	Raloxifene - %	Total number of patients receiving teriparatide	Teriparatide - %	Total number of patients receiving romosozumab	Romosozumab - %	Total number of patients referred to a GP	Referred to GP - %	Total number of patients referred for clinical opinion	Referred for clinical opinion %